Pathological complete response (pCR) to 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) with or without durvalumab (D) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Subgroup analysis by region from the phase 3,...

Authors :: Janjigian, Yelena Y.
Al-Batran, Salah-Eddin
Wainberg, Zev A.
Van Cutsem, Eric
Molena, Daniela
Muro, Kei
Hyung, Woo Jin
Wyrwicz, Lucjan S.
Oh, Do-Youn
Omori, Takeshi
Moehler, Markus
Garrido, Marcelo
Oliveira, Sulene CS
Liberman, Moishe
Castro Oliden, Victor
Bilici, Mehmet
Kurland, John F.
Xynos, Ioannis
Mann, Helen
Tabernero, Josep
Source :: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, pLBA246-LBA246, 6p
Publication Year :: 2024

Full Text Access

Tools